SEC Form 4 · accession 0001623919-16-000100
EndoChoice Holdings, Inc. · GI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
R Scott Huennekens
Director
Period of report
Nov 22, 2016
Accepted (ET)
Nov 23, 2016 · 10:22 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001623919
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stock, par value $0.001 per shareF1,F2 | Nov 22, 2016 | D | 26,666 | $8.00 | D | 0 | I | By Saol Capital LLC |
| Common stock, par value $0.001 per shareF1,F3 | Nov 22, 2016 | D | 8,423 | $8.00 | D | 0 | I | By Front Foot Trust |
| Common stock, par value $0.001 per shareF1 | Nov 22, 2016 | D | 47,446 | $8.00 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reporting Person disposed of shares of Issuer Common Stock pursuant to a cash tender offer made by Boston Scientific Corporation as more fully described in the Schedule 14D-9 filed by Issuer with the Securities and Exchange Commission on October 7, 2016, and subsequent amendments thereto (the "Merger"). The Issuer's Board of Directors approved in advance the dispositions by the Reporting Person in the tender offer.
- F2Saol Capital LLC is owned equally by The Huennekens Family Trust dated June 14, 2007 and The Kieran and Mary Ellen Gallahue Revocable Family Trust dated January 24, 2004, as amended, which hold voting and dispositive power with respect thereto. The Huennekens Family Trust dated June 14, 2007 is owned directly and equally by the reporting person and Deborah Legome Huennekens. The Kieran and Mary Ellen Gallahue Revocable Trust is owned directly and equally by Kieran Thomas Gallahue and Mary Ellen Gallahue. By virtue of the relationships described in this footnote, the entities and individuals described herein may be deemed to beneficially own the shares owned by Saol Capital.
- F3Shares previously directly held by the reporting person were transferred to Front Foot Trust on September 1, 2016. Front Foot Trust is owned directly and equally by the reporting person and Deborah Legome Huennekens and may therefore be deemed to beneficially own the shares owned by Front Foot Trust.